Copyright
©The Author(s) 2018.
World J Nephrol. Jan 6, 2018; 7(1): 29-40
Published online Jan 6, 2018. doi: 10.5527/wjn.v7.i1.29
Published online Jan 6, 2018. doi: 10.5527/wjn.v7.i1.29
Table 1 Representative organ manifestations in IgG4-related disease
Organs adopted at the 1st International symposium in Boston in 2011 | |
Pancreas | Lymphoplasmacytic sclerosing pancreatitis |
Eye/orbit/lacrimal glands | Dacryadenitis/orbital inflammation/pseudotumour |
Salivary glands | Sialoadenitis/Mikulicz disease/Kuttner’s tumor |
Aorta/arteries | Aortitis/periaortitis/arteritis |
Mediastinum/retroperitoneum | Mediastinitis/retroperitoneal fibrosis/mesenteritis |
Kidney | Tubulointerstitial nephritis/renal pyelitis |
Pachimeninges/hypophysis | Pachimeningitis/hypophysitis |
Lung | Lung disease/inflammatory pseudotumor |
Pleura/pericardium | Pleuritis/pericarditis |
Breast | Mastitis |
Bile ducts/gall bladder/ liver | Sclerosing cholangitis/cholecystitis/hepatopathy |
Prostate | Prostatitis |
Skin | Skin disease/pseudolymphoma |
Limph node | Lymphadenopathy |
Organs newly recognized after the Boston meeting | |
Nerve | Infraorbital nerve swelling |
Paranasal sinus | Chronic rhinosinusitis |
Testis/paratestis | Paratesticular pseudotumour |
Ureter | Ureteritis |
Urethra | Urethritis |
Urinary bladder | Interstitial cystitis |
Table 2 Conditions once regarded as individual disorders now recognized to be part of IgG4-related disease
Autoimmune pancreatitis (lymphoplasmacytic sclerosing pancreatitis) |
Eosinophilic angiocentric fibrosis (affecting the orbits and upper respiratory tract) |
Fibrosing mediastinitis |
Hypertrophic pachymeningitis |
Idiopathic hypocomplementemic tubulointerstitial nephritis with extensive tubulointerstitial deposits |
Inflammatory pseudotumour (affecting the orbits, lungs, kidneys, and other organs) |
Küttner’s tumor (affecting the submandibular glands) |
Mikulicz’s disease (affecting the salivary and lacrimal glands) |
Multifocal fibrosclerosis (commonly affecting the orbits, thyroid gland, retroperitoneum, mediastinum, and other tissues and organs) |
Periaortitis and periarteritis |
Inflammatory aortic aneurysm |
Retroperitoneal fibrosis (Ormond’s disease) |
Riedel’s thyroiditis |
Sclerosing mesenteritis |
Table 3 Mimickers of immunoglobulin G4-related disease
Autoimmune | Malignancy | Other |
Antineutrophil cytoplasmic antibody-associated vasculitis | Adenocarcinoma and squamous cell carcinoma | Castleman’s disease |
Granulomatosis with polyangiitis | Extranodal marginal zone lymphoma | Cutaneous plasmocytosis |
Eosinophilic granulomatosis with polyangiitis | Inflammatory myofibroblastic tumor | Erdheim-Chester disease |
Microscopic polyangiitis | Lymphoplasmacytic lymphoma | Inflammatory bowel disease |
Sarcoidosis | Lymphoproliferative disease | Perforating collagenosis |
Sjogren’s disease | Follicular lymphoma | Primary sclerosing cholangitis |
Rhinosinusitis | ||
Rosai-Dorfman disease | ||
Splenic sclerosing angiomatoid nodular transformation | ||
Xanthogranuloma |
Table 4 Clinical presentation of immunoglobulin G4-related disease per site of involvement
Organ system | Nomenclature | Clinical features |
Orbit | IgG4-related ophthalmic disease IgG4-related orbital inflammatory pseudo-tumor IgG4-related pan-orbital inflammation IgG4-related orbital myositis | Swelling of orbital tissue and proptosis |
Lacrimal gland | IgG4-related dacryadenitis | Bilateral swelling of the glands and impaired production of secretion |
Salivary gland | IgG4-related sialoadenitis IgG4-related parotitis IgG4-related submandibular gland disease | Bilateral swelling of the glands and impaired production of secretion |
Thyroid | IgG4-related thyroid disease | Hypothyroidism, neck pain, dysphagia, dyspnea |
Liver | IgG4-related hepatopathy | Jaundice, right upper quadrant mass |
Biliary tract and gall bladder | IgG4-related sclerosing cholangitis IgG4-related cholecystitis | Jaundice, pruritus, cholestasis |
Blood vessels | IgG4-related aortitis/periaortitis IgG4-related periarteritis | Chest pain, dyspnea |
Retroperitoneal fibrosis | IgG4-related retroperitoneal fibrosis | Flank pain, obstructive symptoms, peripheral edema |
Kidneys | IgG4-related kidney disease Tubulo-interstitial nephritis secondary to IgG4-related disease | Hematuria, proteinuria, hypocomplementemia, chronic renal failure |
Skin | IgG4-related skin disease | Papulonodular lesions, plaques, purpura |
Table 5 Major histopathological features associated with immunoglobulin G4-related disease
Dense lymphoplasmacytic infiltrate |
Fibrosis, arranged at least focally in a storiform pattern |
Obliterative phlebitis |
Phlebitis without obliteration of the lumen |
Increased number of eosinophils |
Table 6 Two proposed criteria for IgG4-TIN by the Mayo Clinic and the Japanese Society of Nephrology
Criterion | The Mayo Clinic criteria | JSN criteria |
Histology | Plasma cell-rich TIN with > 10 IgG4+ plasma cells/HPF in the most concentrated field (mandatory criterion) TBM immune complex deposits by immunofluorescence, immunochemistry, and/or electron microscopy | Dense lymphoplasmacytic infiltrate with > 10 IgG4+ plasma cells/HPF and/or IgG4/IgG+ plasma cell ratio of > 40%; Characteristic storiform fibrosis |
Imaging | Small peripheral low-attenuation cortical nodules, round or wedge-shaped lesions, or diffuse patchy involvement | Multiple low-density lesions or enhanced CT, diffuse kidney enlargement, hypovascular solitary nodule, hypertrophic lesion of the renal pelvic wall |
Serology | Elevated serum IgG4 or total IgG level | Elevated serum IgG4 or total IgG level |
Clinical features | None | Clinical or laboratory evidence of kidney damage |
Other organ involvement | Characteristic findings of IgG4-RD in other organs | Characteristic findings of IgG4-RD in other organs |
Definite IgG4-TIN | The histologic feature and at least one other feature from imaging, serology or other organ involvement | The histologic feature (a and b) and at least two of other features from imaging, serology or other organ involvement |
- Citation: Salvadori M, Tsalouchos A. Immunoglobulin G4-related kidney diseases: An updated review. World J Nephrol 2018; 7(1): 29-40
- URL: https://www.wjgnet.com/2220-6124/full/v7/i1/29.htm
- DOI: https://dx.doi.org/10.5527/wjn.v7.i1.29